ADAR1 Capital Management, LLC

13F Holdings History for Grace Therapeutics, Inc. - Common Stock, par value $0.0001 per share (ACST)

Symbol: ACST
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Ownership: 1.53M shares
Security Ownership: 9.9%

Shares, Excluding Options vs Price

Value, Excluding Options

ADAR1 Capital Management GP, LLC ownership in Grace Therapeutics, Inc. Common Stock, par value $0.0001 per share (ACST)

2025-11-14 - ADAR1 Capital Management GP, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1.53M shares of Grace Therapeutics, Inc. Common Stock, par value $0.0001 per share (ACST). This represents 9.9% percent ownership of the company. In their previous filing dated 2025-05-15, ADAR1 Capital Management, LLC had reported owning 1.5M shares, indicating an increase of 2.14% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
ADAR1 Capital Management GP, LLC	9.9%	-0.9%		1.53M	+32,111	+2.14%		13G/A	9/30/2025	14 Nov 2025 19:44:19
ADAR1 Capital Management GP, LLC	9.99%			1.5M				13G/A	3/31/2025	15 May 2025 19:33:34

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2024		-0.56%	$0	0	-959,571	-100%		Q3 2024
6/30/2024	0.56%		$2.8M	960K			$2.92	Q2 2024
3/31/2024	0.2%		$745K	217K			$3.43^*	Q1 2024
12/31/2023	0.04%		$99.8K	34.5K			$2.89	Q4 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.